文源 | 源媒汇作者 | 胡青木编辑 | 苏淮58同城,跨界收购了一家上市药企。日前,易明医药披露的一则实控人变更公告显示,前实控人高帆以15.1元/股的价格,将持有的23%股份转让给了北京福好企业管理(下称“北京福好”)。此次交易完成后,高帆的持股比例降至2.59%,北京福好则以23%的持股比例成为易明医药的控股股东。公告披露的信息显示,股权穿透后,北京福好的实控人为姚劲波与其配偶戴科英。这一...
Source Link文源 | 源媒汇作者 | 胡青木编辑 | 苏淮58同城,跨界收购了一家上市药企。日前,易明医药披露的一则实控人变更公告显示,前实控人高帆以15.1元/股的价格,将持有的23%股份转让给了北京福好企业管理(下称“北京福好”)。此次交易完成后,高帆的持股比例降至2.59%,北京福好则以23%的持股比例成为易明医药的控股股东。公告披露的信息显示,股权穿透后,北京福好的实控人为姚劲波与其配偶戴科英。这一...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.